HPCM
ELV icon

Hunter Perkins Capital Management’s Elevance Health ELV Stock Holding History

Hunter Perkins Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.26M Sell
16,191
-110
-0.7% -$40.8K 1.41% 20
2026
Q1 		$4.77M Sell
16,301
-297
-2% -$97.6K 1.12% 28
2025
Q4 		$5.82M Sell
16,598
-3,983
-19% -$1.35M 1.35% 22
2025
Q3 		$6.65M Buy
20,581
+5,269
+34% +$1.64M 1.47% 22
2025
Q2 		$5.96M Buy
15,312
+2,961
+24% +$1.19M 1.41% 23
2025
Q1 		$5.37M Buy
12,351
+3,048
+33% +$1.22M 1.25% 27
2024
Q4 		$3.43M Buy
+9,303
New +$3.89M 0.72% 40
2023
Q4 		– Sell
-2,000
Closed -$871K – 99
2023
Q3 		$871K Buy
+2,000
New +$907K 0.19% 67

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hunter Perkins Capital Management's ELV Position: Q2 2026 in Review

Hunter Perkins Capital Management reduced its Elevance Health (ELV) stake by 0.67% in Q2 2026, selling an estimated $40.8K and leaving 16,191 shares worth $6.26M. The position accounts for 1.41% of the portfolio, ranked #20.

Hunter Perkins Capital Management first reported a position in ELV in Q3 2023 and has held it in 8 quarters since. The position peaked at $6.65M in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hunter Perkins Capital Management held 16,191 shares of Elevance Health worth $6.26M as of Q2 2026.
  • Hunter Perkins Capital Management sold 110 Elevance Health shares in Q2 2026, an estimated $40.8K.
  • Elevance Health made up 1.41% of Hunter Perkins Capital Management's portfolio in Q2 2026, its #20 holding.
  • Hunter Perkins Capital Management first reported a position in Elevance Health in Q3 2023 and has held it in 8 quarters since.
  • Hunter Perkins Capital Management's Elevance Health position peaked at $6.65M in Q3 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hunter Perkins Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.